Navigation Links
Roche's Pierson Honored as 2009 HBA Rising Star
Date:5/11/2009

NUTLEY, N.J., May 11 /PRNewswire/ -- Roche Product Director Kelly Pierson, of Plainfield, N.J., was honored as a 2009 Rising Star by the Healthcare Businesswomen's Association (HBA) at the organization's annual awards luncheon on May 7, 2009 in New York City.

"Kelly combines her creative nature with meticulous attention to detail. Her energy, inclusive style and strive-for-excellence attitude truly make Kelly a Rising Star," said Richard Hinson, vice president, Commercial Operations.

"Kelly is among our best and brightest. We applaud her for joining the other Roche women who have received this prestigious award. They inspire those around them and contribute tremendously to the success of our company," added George Abercrombie, Roche president and CEO.

Pierson is product director for Boniva(R) (ibandronate sodium), the once-monthly prescription medication for the management of post-menopausal osteoporosis. She joined Roche in 2000 as an Informations Systems Audit Specialist and went on to serve as a manager in Interactive Marketing Management before being named to her current position in 2004. Before Roche, she was with Dun and Bradstreet Corporation and The Prudential. The Philadelphia native earned a B.S. in Accounting from Pennsylvania State University in 1992.

"Kelly is one of the few whose work has quite literally been seen by millions of people," said Hinson, referring to the successful Boniva direct-to-consumer campaign that features actress Sally Field.

"Working in the healthcare industry and in my role in marketing, I get the personal satisfaction of providing women with the information they need to make decisions to better manage their health," said Pierson, who was thrilled to be selected as this year's HBA awardee. "I am truly honored to be recognized as a Rising Star and to be among the amazing Roche women who have been previously recognized."

The HBA, based in Fairfield, N.J. (www.hbanet.org), is a national not-for-profit organization dedicated to furthering the advancement of women in the pharmaceutical and healthcare industries. Its Rising Star Award recognizes women whose outstanding accomplishments make a difference in the industry and inspire others.

Past Roche HBA Rising Stars include Sarah Vidal, Product Marketing; Suzann Duncan, Product Marketing; Stella Xu, Pharma Partnering; Cathy Geddes, HCV Management; Kathy Presto, Medical Affairs; Lori Martin, Marketing Administration; and Michelle Zupancic, Specialty Business Operations. Carolyn Glynn, vice president, Public Affairs, is a past HBA Woman of the Year.

About HBA

The Healthcare Businesswomen's Association, founded in 1977, is a global organization dedicated to the advancement of women in healthcare and provides professional development and recognition, networking and mentoring programs and leadership opportunities for its 5,000 members. For more information, visit www.hbanet.org.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2008, Roche was named one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as Top Company of the Year by Med Ad News, a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit http://www.rocheusa.com. Product and treatment information for U.S. healthcare professionals is available at www.RocheExchange.com.

All trademarks used or mentioned in this release are protected by law.

    Contact:  Darien E. Wilson
              Public Affairs
              973-562-2232
              darien_e.wilson@roche.com
     


'/>"/>
SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Reports Second Quarter Results
2. Rochester Medical Announces Second Quarter 2009 Earnings Conference Call April 30, 2009
3. Rochester Medical Renews Share Repurchase Activity
4. University of Rochester Launches iTraining for Emergency Responders
5. Rochester Medical Reports First Quarter Results
6. Rochester study raises new questions about controversial plastics chemical
7. Rochester Medical Announces First Quarter 2009 Earnings Conference Call February 2, 2009
8. Rochester Medical Announces Settlement With TYCO Healthcare Group, L.P., Now Operating as Covidien Ltd.
9. Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care
10. Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales
11. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... , ... May 31, 2016 ... ... healthcare that considers individuals’ genetic characteristics and the physical and behavioral worlds ... work in sync. In personalized medicine, diagnosing an individual’s disease depends on ...
(Date:5/31/2016)... HOUSTON, TEXAS (PRWEB) , ... May 31, 2016 ... ... is live in Greater Houston Healthconnect’s (Healthconnect) regional health information exchange, which enables ... prior medical records for their patients from other participating organizations in the exchange. ...
(Date:5/31/2016)... ... 31, 2016 , ... CallTrackingMetrics's software gives healthcare ... the performance of sales and support staff, and to efficiently route calls to ... customers to record, transcribe, route, document, and report on everything going on in ...
(Date:5/31/2016)... , ... May 31, 2016 , ... The Global ... today released ten predictions on the future of wellness, travel, spa and beauty in ... travel, spa and beauty companies to leading economists and researchers - to forecast where ...
(Date:5/31/2016)... ... 2016 , ... Interest is on the rise for using the CRISPR-Cas9 system ... for RNAi hit validation. A key reason may be that high-throughput synthesis—combined with a ... RNA (crRNA) collections in arrayed formats. , Arrayed crRNA screens have ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... -- A key trend that will boost ... new treatments. Cardax, a development stage life sciences company, ... is expected to fulfil large unmet medical needs in ... to develop new treatments for osteoarthritis. One such study ... osteoarthritis are being investigated, and early trials of stem-cell ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: